Skip to main content
SpringerLink
Log in

Intrathecal Baclofen Therapy: Assessment and Medical Management

  • Reference work entry
  • First Online:
Book cover Cerebral Palsy

  • 70 Accesses

Abstract

Intrathecal baclofen therapy has been used in the treatment of generalized spasticity in children since 1996. It has also been noted to help decrease dystonia in this population. It is very important to understand the pathophysiology of these conditions and the range of treatments available. Careful assessment is needed to determine whether someone is a good candidate for intrathecal baclofen therapy. Ideally a multidisciplinary team including the patient and family should work together to create realistic goals for treatment including improving function, comfort, and ease of care. All medical issues need to be understood and followed closely before and after intrathecal pump implantation. A screening trial can be performed but is not necessary prior to pump implantation. Optimizing dose titration and catheter tip positioning can help to maximize treatment effects. Medical and surgical complications have been recognized and need to be worked up and managed efficiently. The benefits of intrathecal baclofen therapy have been widely published and include improvement in comfort and function but most importantly in quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,299.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,699.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbott R (1996) Selective rhizotomy for treatment of childhood spasticity. J Child Neurol 11:S36–S42

    Google Scholar 

  • Abousamra O, Rogers KG, McManus M et al (2016) Evaluation of intrathecal baclofen delivery system malfunction by computed tomography scan. Dev Med Child Neurol 58:409–415

    Google Scholar 

  • Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265:1418–1422

    CAS  Google Scholar 

  • Albright AL, Barron WB, Fasick MP et al (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270:2475–2477

    CAS  Google Scholar 

  • Albright AL, Barry MJ, Fasick MP et al (1995) Effects of continuous intrathecal baclofen infusion and selective dorsal rhizotomy on upper extremity spasticity. Pediatr Neurosurg 23:82–85

    CAS  Google Scholar 

  • Albright AL, Barry MJ, Fasick MP et al (1996) Continuous intrathecal baclofen for symptomatic generalized dystonia. Neurosurgery 38:934–939

    CAS  Google Scholar 

  • Albright AL, Thompson CS, Minnigh MB (2007) Cerebrospinal fluid baclofen concentrations in patient undergoing continuous intrathecal baclofen therapy. Dev Med Child Neurol 49:423–425

    Google Scholar 

  • Armstrong RW (1992) Intrathecal baclofen and spasticity: what do we know and what do we need to know? Dev Med Child Neurol 34:739–745

    CAS  Google Scholar 

  • Armstrong RW, Steinbok P, Cochrane DD et al (1997) Intrathecally administered baclofen for the treatment of children with spasticity of cerebral palsy. J Neurosurg 87:409–414

    CAS  Google Scholar 

  • Bayhan I, Sees JP, Nishnianidze T (2016) Infection as a complication of intrathecal baclofen treatment in children with cerebral palsy. J Pediatr Orthop 36:305–309

    Google Scholar 

  • Boster AL, Bennett S, Bilsky G et al (2016a) Best practices for intrathecal baclofen therapy: screening test. Neuromodulation 19:616–622

    Google Scholar 

  • Boster AL, Adair R, Gooch JL et al (2016b) Best practices for intrathecal baclofen therapy: dosing and long term management. Neuromodulation 19:623–631

    Google Scholar 

  • Butler C, Campbell S (2000) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee review Panel. Dev Med Child Neurol 42:634–645

    CAS  Google Scholar 

  • Campbell SK, Almeida GL, Penn RD et al (1995) The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 75:352–362

    CAS  Google Scholar 

  • Frost F, Nanninga J, Penn R (1989) Intrathecal baclofen infusion: effects on bladder management programs in patients with myelopathy. Am J Phys Med Rehabil 68:112–115

    CAS  Google Scholar 

  • Gans B, Glenn M (1990) In: Glenn M, Whyte J (eds) The practical management of spasticity in children and adults. Lea & Febiger, Philadelphia, pp 1–7

    Google Scholar 

  • Gerszten PC, Albright AL, Barry MJ (1997) Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 27:40–44

    CAS  Google Scholar 

  • Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with cerebral palsy. J Neurosurg 88:1009–1013

    CAS  Google Scholar 

  • Gormley ME Jr (1999) Management of spasticity in children. Part 2: oral and intrathecal baclofen. J Head Trauma Rehabil 2:207–209

    Google Scholar 

  • Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter placement for intrathecal baclofen administration in children with quadriplegic spasticity. Neurosurgery 45:833–837

    CAS  Google Scholar 

  • Katz RT, Campagnolo DI (1994) Pharmacologic management of spasticity. Phys Med Rehabil State Art Rev 8:473–480

    Google Scholar 

  • Keenan C, Alexander M, Sung I et al (2000) Intrathecal baclofen for treatment of spasticity in children. Phys Med Rehabil State Art Rev 12:275–283

    Google Scholar 

  • Keisswetter H, Schober W (1975) Lioresal in the treatment of neurogenic bladder dysfunction. Urol Int 30:63–71

    Google Scholar 

  • Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol 16:31–36

    CAS  Google Scholar 

  • Kroin JS (1992) Intrathecal drug administration, present use and future trends. Clin Pharmacokinet 22:319–326

    CAS  Google Scholar 

  • Kroin JS, Ali A, York M et al (1993) The distribution of medication along the spinal cord after chronic intrathecal administration. Neurosurgery 33:226–230

    CAS  Google Scholar 

  • Lance JW (1980) Symposium synopsis. In: Young RR, Feldman RG, Koella WP (eds) Spasticity: disordered motor control. Symposia Specialists, Miami, pp 485–495

    Google Scholar 

  • Massagli TL (1991) Spasticity and its management in children. Phys Med Rehabil Clin N Am 2:867–889

    Google Scholar 

  • Mathur SN, Chu SK, McCormick Z et al (2014) Long-term intrathecal baclofen:outcomes after more than 10 years of treatment. PM & R 6:506–513

    Google Scholar 

  • McCormick ZL, Chu SK, Binler D et al (2016) Intrathecal versus oral baclofen: a matched cohort study of spasticity, pain, sleep, fatigue, and quality of life. PM & R 8:551–562

    Google Scholar 

  • McMahon M, Pruitt D et al (2015) Cerebral palsy. In: Alexander MA, Matthews D (eds) Pediatric rehabilitation principles and practice. Demos Medical, New York, pp 336–364

    Google Scholar 

  • Medtronic ITB (2017a) The effects of magnetic resonance imaging (MRI) on SyncroMed II drug infusion systems, Therapy product monograph. Medtronic Inc., Minneapolis

    Google Scholar 

  • Medtronic ITB (2017b) The effects of magnetic resonance imaging (MRI) on SyncroMed II drug infusion systems, Therapy technical note. Medtronic Inc., Minneapolis

    Google Scholar 

  • Meythaler JM, Guin-Renfroe S, Grabb P et al (1999) Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 80:13–19

    CAS  Google Scholar 

  • Meythaler JM, Guin-Renfroe S, Law C et al (2001) Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 82:155–161

    CAS  Google Scholar 

  • Miller F (1998) Gait analysis in cerebral palsy. In: Dormans JP, Pellegrino L (eds) Caring for the child with cerebral palsy. Brookes, Baltimore, pp 169–191

    Google Scholar 

  • Muller H, Zierski J, Dralle D (1988) Pharmacokinetics of intrathecal baclofen in spasticity. In: Muller X, Zierski J, Penn RD (eds) Local-spinal therapy of spasticity. Springer, Berlin, pp 223–226

    Google Scholar 

  • Muller-Schwefe G, Penn RD (1989) Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases. J Neurosurg 71:273–275

    CAS  Google Scholar 

  • Nanninga JB, Frost F, Penn R (1989) Effect of intrathecal baclofen on bladder and sphincter control. J Urol 142:101–105

    CAS  Google Scholar 

  • Peacock W, Straudt L (1991) Functional outcomes following selective posterior rhizotomy in children with cerebral palsy. J Neurosurg 74:380–385

    CAS  Google Scholar 

  • Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1:1078

    CAS  Google Scholar 

  • Penn RD, Savoy SM, Corcos D et al (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517–1521

    CAS  Google Scholar 

  • Pin TM, McCartney L, Lewis J et al (2011) Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Dev Med Child Neurol 53:885–895

    Google Scholar 

  • Price GW, Wilkins GP, Turnbull MJ et al (1984) Are baclofen-sensitive GABAb receptors present on primary afferent terminals of the spinal cord? Nature 307:71–74

    CAS  Google Scholar 

  • Ried S, Pellegrino L, Albinson-Scull S et al (1998) The management of spasticity. In: Dormans JP, Pellegrino L (eds) Caring for the child with cerebral palsy. Brookes, Baltimore, pp 99–123

    Google Scholar 

  • Rosenson AS, Ali A, Fordham EW (1990) Indium-111 DTPA flow study to evaluate surgically implanted drug pump delivery system. Clin Nucl Med 15:154–156

    CAS  Google Scholar 

  • Sampathkumar P, Scanlon PD, Plevak DJ (1998) Baclofen withdrawal presenting as multi-organ system failure. J Neurosurg 88:562–563

    Google Scholar 

  • Saulino M, Ivanho C, McGuire JR et al (2016a) Best practices for intrathecal baclofen therapy: patient selection. Neuromodulation 19:607–615

    Google Scholar 

  • Saulino M, Anderson DJ, Doble J (2016b) Best practices for intrathecal baclofen therapy:troubleshooting. Neuromodulation 19:632–641

    Google Scholar 

  • Yoon YK, Lee KC, Cho HE et al (2017) Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Medicine 96(34):e7472

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nemours Alfred I Dupont Hospital for Children, Wilmington, DE, USA

    Maura McManus

Authors
  1. Maura McManus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maura McManus .

Editor information

Editors and Affiliations

  1. Department of Orthopaedics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Freeman Miller

  2. Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, USA

    Steven Bachrach

  3. Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Nancy Lennon

  4. Columbia University, Irving Medical Center, Programs in Physical Therapy, New York, NY, USA

    Margaret E. O'Neil

Section Editor information

  1. AI DuPont Hospital for Children, Wilmington, DE, USA

    Freeman Miller

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

McManus, M. (2020). Intrathecal Baclofen Therapy: Assessment and Medical Management. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M.E. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-74558-9_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74558-9_44

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74557-2

  • Online ISBN: 978-3-319-74558-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation